UPDATED Jun 27, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2698 | CN¥12.15 | -5.3% | -30.5% | CN¥12.4b | CN¥15.00 | PE23.3x | E21.9% | 2.1% | Capital Goods | ||
300723 | CN¥19.65 | -7.7% | -32.9% | CN¥8.8b | CN¥30.72 | PE50.7x | E29.3% | 1.1% | Pharmaceuticals & Biotech | ||
603171 | CN¥27.04 | 18.8% | -32.4% | CN¥11.0b | CN¥39.29 | PE130.8x | E47.3% | 0.6% | Software | ||
2024 | CN¥1.29 | 4.0% | -33.5% | CN¥11.8b | CN¥2.10 | PB1x | E105.4% | 0% | Retail | ||
688369 | CN¥15.73 | -6.0% | -71.6% | CN¥1.8b | CN¥24.00 | PS1.7x | E73.8% | 0.8% | Software |